Clinical Trials

NCT06001749 | RECRUITING | PHASE2
15 participants

Psilocybin in Cancer Pain Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2024-09-23
Completion:
2026-10-01
Conditions
  • Opioid-Related Disorders
  • Pain Management
  • Pain Management and Care
  • Advanced Cancer
  • Advanced Cancers
Interventions
  • DRUG
No Results Yet
NCT05943626 | RECRUITING | NA
20 participants

Circadian Intervention to Improve Cardiometabolic Health

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2023-06-13
Completion:
2026-12-31
Conditions
  • Cardiometabolic Syndrome
  • Type 2 Diabetes
  • Sleep
  • Time Restricted Feeding
  • Lifestyle Factors
  • Overweight and Obesity
  • Insulin Sensitivity
  • Eating Habit
  • Sleep Hygiene
Interventions
  • BEHAVIORAL
No Results Yet
NCT05886036 | RECRUITING | PHASE2
70 participants

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2024-01-23
Completion:
2026-10-31
Conditions
  • Nodular Lymphocyte Predominant B-Cell Lymphoma
  • Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma
  • Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT05812807 | RECRUITING | PHASE3
1295 participants

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2023-06-14
Completion:
2033-05-31
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Early Stage Triple-Negative Breast Carcinoma
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • OTHER
  • PROCEDURE
No Results Yet
NCT05677490 | RECRUITING | PHASE3
382 participants

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2023-01-31
Completion:
2028-11-08
Conditions
  • Advanced Esophageal Adenocarcinoma
  • Advanced Gastric Adenocarcinoma
  • Advanced Gastroesophageal Junction Adenocarcinoma
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Gastric Cancer AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IV Gastric Cancer AJCC v8
  • Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Unresectable Esophageal Adenocarcinoma
  • Unresectable Gastric Adenocarcinoma
  • Unresectable Gastroesophageal Junction Adenocarcinoma
Interventions
  • DRUG
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page